Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avichai Shimoni

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Rheumatology (Oxford, England)|June 24, 2026
CAR-T as a salvage treatment in polyrefractory rheumatoid arthritisMerav Lidar, Paula David, Elad Jacoby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2013
The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myelomaAmnon Peled, Michal Abraham, Irit Avivi, et al.
Communications Biology|January 17, 2020
Discovery of tumoricidal DNA oligonucleotides by response-directed in vitro evolutionNoam Mamet, Yaniv Amir, Erez Lavi, et al.
Cells|April 12, 2022
Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell MalignanciesKatia Beider, Orit Itzhaki, Jacob Schachter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantationArnon Nagler, Vanderson Rocha, Myriam Labopin, et al.
British Journal of Haematology|May 27, 2005
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Bronwen Shaw, Simona Iacobelli, et al.
British Journal of Haematology|September 13, 2021
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMTAvichai Shimoni, Marie Robin, Simona Iacobelli, et al.
Haematologica|July 22, 2008
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantationFrancis Ayuk, José A Perez-Simon, Avichai Shimoni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patientsMichal J Besser, Ronnie Shapira-Frommer, Avraham J Treves, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Rheumatology (Oxford, England)|June 24, 2026
CAR-T as a salvage treatment in polyrefractory rheumatoid arthritisMerav Lidar, Paula David, Elad Jacoby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2013
The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myelomaAmnon Peled, Michal Abraham, Irit Avivi, et al.
Communications Biology|January 17, 2020
Discovery of tumoricidal DNA oligonucleotides by response-directed in vitro evolutionNoam Mamet, Yaniv Amir, Erez Lavi, et al.
Cells|April 12, 2022
Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell MalignanciesKatia Beider, Orit Itzhaki, Jacob Schachter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantationArnon Nagler, Vanderson Rocha, Myriam Labopin, et al.
British Journal of Haematology|May 27, 2005
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Bronwen Shaw, Simona Iacobelli, et al.
British Journal of Haematology|September 13, 2021
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMTAvichai Shimoni, Marie Robin, Simona Iacobelli, et al.
Haematologica|July 22, 2008
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantationFrancis Ayuk, José A Perez-Simon, Avichai Shimoni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patientsMichal J Besser, Ronnie Shapira-Frommer, Avraham J Treves, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Pageof 17